Akoya Biosciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $23,164 | $18,350 | $26,487 | $25,215 |
Gross Profit | 13,386 | 8,379 | 14,746 | 15,276 |
EBITDA | -9,070 | -14,987 | -6,716 | -12,795 |
EBIT | -10,996 | -17,038 | -8,822 | -15,371 |
Net Income | -13,149 | -23,484 | -10,802 | -12,916 |
Net Change In Cash | 23,164 | 18,350 | 26,487 | 25,215 |
Free Cash Flow | -11,211 | -21,634 | -6,145 | -14,585 |
Cash | 8,923 | 13,039 | 83,125 | 78,595 |
Basic Shares | 49,419 | 49,188 | 49,089 | 48,975 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $96,633 | $74,859 | $54,917 | $42,443 |
Gross Profit | 48,238 | 43,390 | 34,218 | 25,908 |
EBITDA | -47,142 | -59,332 | -32,909 | -7,638 |
EBIT | -56,032 | -66,481 | -37,701 | -11,453 |
Net Income | -63,323 | -70,641 | -42,935 | -16,706 |
Net Change In Cash | 96,633 | 74,859 | 54,917 | 42,443 |
Cost of Revenue | -38,849 | 95,873 | ||
Free Cash Flow | -54,552 | -60,856 | -41,162 | -10,138 |
Cash | 83,125 | 74,229 | 113,079 | 17,006 |
Basic Shares | 44,434 | 37,746 | 37,424 | 37,110 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.27 |
2024-03-31 | -$0.48 |
2023-12-31 | -$0.22 |
2023-09-30 | -$0.26 |
